D68.312
Antiphospholipid antibody with hemorrhagic disorder
HCC risk adjustment mapping
CMS-HCC ESRD V24
Coagulation Defects and Other Specified Hematological Disorders
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
antiphospholipid antibody, finding without diagnosis (R76.0) lupus anticoagulant (LAC) finding without diagnosis (R76.0) systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
antiphospholipid antibody syndrome (D68.61) antiphospholipid antibody with hypercoagulable state (D68.61) lupus anticoagulant (LAC) with hypercoagulable state (D68.62) systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
Lupus anticoagulant (LAC) with hemorrhagic disorder Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Official Guidelines for D68.312
FY 2026 ›Find D68.312 in the alphabetic index
8 index paths lead to this code
- Antiphospholipid › antibody › with hemorrhagic disorder
- Antibody › anticardiolipin › with › hemorrhagic disorder
- Antibody › antiphosphatidylglycerol › with › hemorrhagic disorder
- Antibody › antiphosphatidylinositol › with › hemorrhagic disorder
- Antibody › antiphosphatidylserine › with › hemorrhagic disorder
- Antibody › antiphospholipid › with › hemorrhagic disorder
- Lupus › anticoagulant › with › hemorrhagic disorder
- Lupus › erythematosus › systemic › inhibitor › with › hemorrhagic disorder